ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS
ACTR-04. 生物标志物:贝伐珠单抗治疗新诊断胶质母细胞瘤进展期后的 II 期研究:安全性、有效性和前瞻性生物标志物分析
期刊:
影响因子:
doi:10.1227/ons.0000000000000870
Dagra, Abeer; Kurian, Annu L; Lucke-Wold, Brandon; Hengartner, Astrid C; Prince, Eric; Staulcup, Susan; Vijmasi, Trinka; Souweidane, Mark; Jackson, Eric M; Johnston, James M; Anderson, Richard C E; Naftel, Robert P; Grant, Gerald; Niazi, Toba N; Dudley, Roy; Limbrick, David D; Ginn, Kevin; Smith, Amy; Kilburn, Lindsay; Jallo, George; Wilkening, Greta; Hankinson, Todd; Ichimura, Koichi; Nagane, Motoo; Kato, Mamoru; Narita, Yoshitaka; Aoki, Tomokazu; Tanaka, Shota; Mukasa, Akitake; Wakabayashi, Toshihiko; Uzuka, Takeo; Nakamura, Hideo; Arakawa, Yoshiki; Suehiro, Satoshi; Nakada, Mitsutoshi; Kitahara, Mai; Hibiya, Yuko; Narushima, Daichi; Onuki, Ritsuko; Morita, Satoshi; Nishikawa, Ryo